These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3423055)

  • 21. [Ophthalmologic follow-up examination in Kawasaki syndrome (mucocutaneous lymph node syndrome)].
    Krüger H; Poetzsch-Heffter R
    Fortschr Ophthalmol; 1986; 83(2):181-3. PubMed ID: 3710366
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of Kawasaki syndrome by intravenous gamma globulins. A medium-term clinical and paraclinical study of 5 cases].
    Lebranchu Y; Despert F; Borderon JC; Bloc D; Renoux M; Bardos P; Laugier J
    Ann Pediatr (Paris); 1986 Nov; 33(9):809-13. PubMed ID: 3492169
    [No Abstract]   [Full Text] [Related]  

  • 23. Difficulties in performing clinical trials of antithrombotic therapy in neonates and children.
    Massicotte MP; Sofronas M; deVeber G
    Thromb Res; 2006; 118(1):153-63. PubMed ID: 16009401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of atypical Kawasaki disease.
    Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermatological aspects of the Kawasaki syndrome (mucocutaneous lymph node syndrome, MCLS).
    Doerfer J; Wässer S
    Dermatol Monatsschr; 1986; 172(4):212-6. PubMed ID: 3721027
    [No Abstract]   [Full Text] [Related]  

  • 26. [From empiricism to therapeutic trials. Or how statistical methods can contribute to the improvement of therapeutic protocols in cervicofacial oncology].
    Cachin Y; Flamant R; Richard J; Sancho-Garnier H
    Ann Otolaryngol Chir Cervicofac; 1982; 99(1-2):47-52. PubMed ID: 7103330
    [No Abstract]   [Full Text] [Related]  

  • 27. Statistical methods in clinical trials.
    Gebski VJ; Keech AC
    Med J Aust; 2003 Feb; 178(4):182-4. PubMed ID: 12580749
    [No Abstract]   [Full Text] [Related]  

  • 28. Statistical methods in clinical trials.
    Goadsby PJ
    Med J Aust; 2003 Jul; 179(2):119-20; author reply 120. PubMed ID: 12864729
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mucocutaneous lymph node syndrome (Kawasaki disease). Presentation of 3 cases].
    Hernández Lorca A; Bentiez Rubio MR; García Santiago M; Hernández Delgado J; García Suárez E; González Mediero I; Silgo Pujalte M; García Pérez J
    An Esp Pediatr; 1983 Jul; 19(1):59-64. PubMed ID: 6638713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Febrile torticollis: an atypical presentation of Kawasaki disease].
    Runel-Belliard C; Lasserre S; Quinet B; Grimprel E
    Arch Pediatr; 2009 Feb; 16(2):115-7. PubMed ID: 19112010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease modifying trials in Alzheimer disease: methodological and statistical issues.
    Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
    J Nutr Health Aging; 2006; 10(2):116-7. PubMed ID: 16554944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Discharge instructions for children with Kawasaki disease].
    Mizuno Y; Andoh H; Oshima K; Sakurai Y
    Kango Gijutsu; 1983 Sep; 29(12):1610-4. PubMed ID: 6558185
    [No Abstract]   [Full Text] [Related]  

  • 33. Issues in amyotrophic lateral sclerosis clinical trial design.
    Munsat TL
    Adv Neurol; 1995; 68():209-18. PubMed ID: 8787231
    [No Abstract]   [Full Text] [Related]  

  • 34. [Kawasaki syndrome].
    Gaudelus J; Belasco C; Ovetchkine P; Camard O
    Rev Prat; 1997 Sep; 47(13):1442-6. PubMed ID: 9339024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoantibodies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)].
    Saji T; Umezawa T; Hashiguchi R; Matsuo N
    Arerugi; 1983 Dec; 32(12):1129-33. PubMed ID: 6678147
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypothesis testing vs. statistical estimation procedures in caries clinical trials.
    Fertig JW
    J Dent Res; 1984 May; 63 Spec No():808-13. PubMed ID: 6586785
    [No Abstract]   [Full Text] [Related]  

  • 37. [Decision making in clinical research: a statistical approach].
    Lacaine F; Huguier M
    Gastroenterol Clin Biol; 1980 Nov; 4(11):754-7. PubMed ID: 7461386
    [No Abstract]   [Full Text] [Related]  

  • 38. The scientific basis of clinical trials: statistical aspects.
    Gehan EA
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma prostaglandin E2 and F2 alpha levels in patients with mucocutaneous lymph node syndrome (Kawasaki disease) and anaphylactoid purpura].
    Lee T
    Arerugi; 1985 Mar; 34(3):147-54. PubMed ID: 3862369
    [No Abstract]   [Full Text] [Related]  

  • 40. Sudden death in an adolescent four years after recovery from mucocutaneous lymph node syndrome (Kawasaki disease).
    Quam JP; Edwards WD; Bambara JF; Luzier TL
    J Forensic Sci; 1986 Jul; 31(3):1135-41. PubMed ID: 3734732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.